Eisai: Approval of Antiepileptic Drug Fycompa in Japan for Monotherapy and Pediatric Indications for Partial-Onset Seizures, as well as a New Formulation
- Written by ACN Newswire - Press Releases
.
More Articles ...
- China New City (1321.HK) and Maggie Rose Champion Quality Family Time
- Azelis presents new regional video for Asia Pacific, reinforcing its whole-hearted commitment to innovation through formulation
- Mitsubishi Motors concludes a disaster cooperation agreement for the first time in Tokyo with Minato City
- HKTDC Education Careers Expo opens early February
- Suprema unveils its Latest Facial Recognition Solution at INTERSEC 2020
- Invest Hong Kong assists record number of Overseas and Mainland Companies setting up or expanding in Hong Kong
- Invest Hong Kong of the Hong Kong Special Administrative Region Government assists record number of overseas and Mainland companies setting up or expanding in Hong Kong
- JCB expands its merchant network with Nets Group in Finland
- Bityuan 2019: Sailing from China, Chaining the World
- Showa Denko to Streamline Domestic Production of Unsaturated Polyester Resin and Vinyl Ester Resin
Magazine
How Long Does Botox Really Last? A Realistic Timeline
Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...
Compressed Air Pipe and Fittings: What Every Australian Industrial Facility Needs to Know
Compressed air is the fourth utility of modern industry, right alongside electricity, gas, and water. Yet despite its critical role in powering everything from pneumatic tools to automated productio...
Common Risks Hidden in Commercial Lease Agreements
Commercial leases are often longer and more complex than tenants expect, and the fine print can carry significant financial and operational consequences over the years that follow. Many business own...